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Abstract
AIM
To determine the prevalence of gastrointestinal 
neoplasia among dermatomyositis patients who 
underwent an esophagogastroduodenoscopy and/or 
colonoscopy.
METHODS
A cross-sectional study examining the results of 
upper endoscopy and colonoscopy in adults with 
dermatomyositis at an urban, university hospital over 
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a ten year period was performed. Chart review was 
performed to confirm the diagnosis of dermatomyositis. 
Findings on endoscopy were collected and statistical 
analyses stratified by age and presence of symptoms 
were performed.
RESULTS
Among 373 adult patients identified through a 
code based search strategy, only 163 patients had 
dermatomyositis confirmed by chart review. Of the 
47 patients who underwent upper endoscopy, two 
cases of Barrett’s esophagus without dysplasia were 
identified and there were no cases of malignancy. Of 
the 67 patients who underwent colonoscopy, no cases 
of malignancy were identified and an adenoma was 
identified in 15% of cases. No significant differences 
were identified in the yield of endoscopy when stratified 
by age or presence of symptoms.
CONCLUSION
The yield of endoscopy is low in patients with 
dermatomyositis and is likely similar to the general 
population; we identified no cases of malignancy. 
A code based search strategy is inaccurate for the 
diagnosis of dermatomyositis, calling into question 
the results of prior population-based studies. Larger 
studies with rigorously validated search strategies are 
necessary to understand the risk of gastrointestinal 
malignancy in patients with dermatomyositis.
Key words: Endoscopy; Dermatomyositis; Colon cancer; 
Screening
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Core tip: Dermatomyositis is associated with an 
increased risk of gastrointestinal (GI) malignancies 
based on large-population based studies. These prior 
studies utilized code-based search strategies and 
did not perform individual chart review. The yield of 
endoscopy in this patient population is not known. In 
this study, endoscopy identified no cases of malignancy 
and was of low yield, likely similar to the general 
population, in the identification of pre-malignant 
findings. Code-based searched strategies were 
inaccurate in the identification of dermatomyositis, 
calling into question the results of prior population-
based studies. The association between increased GI 
malignancy and dermatomyositis may be lower than 
previously reported.
Kidambi TD, Schmajuk G, Gross AJ, Ostroff JW, Terdiman 
JP, Lee JK. Endoscopy is of low yield in the identification of 
gastrointestinal neoplasia in patients with dermatomyositis: 
A cross-sectional study. World J Gastroenterol 2017; 23(26): 
4788-4795  Available from: URL: http://www.wjgnet.
com/1007-9327/full/v23/i26/4788.htm  DOI: http://dx.doi.
org/10.3748/wjg.v23.i26.4788
INTRODUCTION
Patients with dermatomyositis, a common idiopathic 
inflammatory myopathy characterized by muscle 
weakness and cutaneous findings affecting appro­
ximately 1 per 100000 people are generally considered 
to have an increased prevalence of gastrointestinal 
(GI) malignancy[1,2]. However, the reported pre­
valence of GI malignancy varies depending on the 
level of chart review or diagnostic codes used to 
verify the diagnoses[3­9]. Large population­based 
studies[3­5] utilizing diagnostic codes for identifying 
dermatomyositis patients have reported a prevalence 
of GI malignancy as high as five percent. Additionally, 
a study using extensive testing for malignancy in 
dermatomyositis patients reported a 15% prevalence 
of GI malignancy[6]. In contrast, small retrospective 
studies[7­9] utilizing individual level chart review 
have reported the prevalence of gastric or colorectal 
cancer (CRC) to be closer to one percent among 
dermatomyositis patients. 
Currently, there are no guidelines that recommend 
an initial endoscopic workup for evaluation of an 
underlying GI malignancy in dermatomyositis patients. 
However, given the reported increased prevalence of 
GI neoplasia, many providers recommend an upper 
esophagogastroduodenoscopy (EGD) and colonoscopy 
as part of routine clinical care among dermatomyositis 
patients despite the lack of signs, symptoms, or 
laboratory abnormalities to suggest a GI source. To 
date, there are no data regarding the utility of this 
practice among dermatomyositis patients. Therefore, 
the aim of this study was to determine the prevalence 
of GI neoplasia among dermatomyositis patients who 
underwent an EGD and/or colonoscopy.
MATERIALS AND METHODS
Study population
This retrospective, cross­sectional study was conducted 
at the University of California, San Francisco (UCSF), 
an academic, tertiary care medical center serving 
over 1.2 million people in the San Francisco Bay 
Area. Patients with dermatomyositis were referred to 
either UCSF’s rheumatology, dermatology, or gastro­
enterology clinics. 
Study oversight
The study was approved by the UCSF institutional 
review board, which waived the requirement for 
informed consent. The listed authors had sole res­
ponsibility for the study design, data collection, 
decision to submit the manuscript for publication, and 
drafting of the manuscript. 
Study eligibility criteria
We included all dermatomyositis patients 18 years 
of age and above seen at UCSF between January 
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2005­February 2016, who had an endoscopy (EGD 
and/or colonoscopy) at or after their dermatomyositis 
diagnosis. We selected this time period because of 
the availability of electronic health records. To identify 
patients with dermatomyositis seen at UCSF, we 
performed a comprehensive search of our electronic 
medical record using International Classification 
of Diseases (ICD)­9 and ICD­10 diagnoses codes 
(Supplementary Table 1). We also reviewed a sepa­
rate query of the electronic medical record initiated 
by UCSF’s rheumatology division, which utilized a 
combination of ICD­9 and ICD­10 codes as well 
as clinic modifiers used for research purposes by 
the rheumatology clinic, to identify any additional 
dermatomyositis patients that may have been missed 
by our diagnostic code search. After the initial search, 
two reviewers (TDK, JKL) manually reviewed each 
chart to confirm the diagnosis of dermatomyositis. We 
defined a dermatomyositis diagnosis as any patient 
seen in either rheumatology and/or dermatology 
clinic with a diagnosis of dermatomyositis made 
by histological and/or clinical criteria; patients with 
an overlap rheumatologic condition that included 
dermatomyositis were included. For any charts 
where the diagnosis of dermatomyositis was unclear 
or with discordant results by the two reviewers, a 
rheumatologist was used for adjudication.
Data sources and variables
We obtained patient demographic and clinical 
information for each dermatomyositis patient included 
in this study from our electronic medical records, which 
included clinic notes, consultation notes, endoscopy 
reports, pathology reports, radiology reports, and 
cancer diagnoses. Age and disease duration were 
defined as the age at the end of the study period or 
the difference in years between the patients’ date 
of birth and the end of the study period (February 
2016), respectively. For patients who underwent an 
endoscopy, data on age and disease duration at the 
time of endoscopy was collected. Findings on EGD 
were categorized as normal, pre­malignant, malignant, 
or non­malignant. Gastric and duodenal erosions with 
non-specific inflammation on histology were included 
as normal. Pre­malignant findings on EGD included 
Barrett’s esophagus (with or without dysplasia), gastric 
intestinal metaplasia (with or without dysplasia) 
and duodenal adenoma. Malignant findings on EGD 
included carcinoma of the esophagus, stomach or 
duodenum. Non­malignant findings included erosive 
esophagitis, infectious esophagitis (such as candidiasis 
or cytomegalovirus infection) and helicobacter pylori 
infection, all of which were confirmed on histology, 
as well as esophago­gastric varices. If subsequent 
EGDs were performed after the initial endoscopy, the 
findings were collected and the highest risk finding 
was recorded.
Findings on colonoscopy were categorized as 
normal, pre­malignant, malignant, or non­malignant. 
Diverticulosis, distal hyperplastic polyps and non­
specific findings on endoscopy with normal histology 
(such as “thickened folds” or “nodules”) were included 
as normal. Pre­malignant findings included any 
colonic adenoma, proximal serrated lesions, and were 
further categorized as advanced adenomas or low­
risk adenomas. We defined an advanced adenoma as 
any adenoma of any size with high grade dysplasia or 
a villous component or an adenoma greater than ten 
millimeters in size, low risk tubular adenomas, defined 
as less than three adenomas not meeting criteria for an 
advanced adenoma, or higher risk tubular adenomas, 
defined as three of more tubular adenomas found 
on a single colonoscopy. Malignancy was defined as 
carcinoma of the colon, including adenocarcinoma and 
neuroendocrine neoplasms. Non­malignant findings 
included inflammatory bowel disease and microscopic 
colitis. If subsequent colonoscopies were performed 
after the initial colonoscopy, the findings were collected 
and the highest risk finding was recorded. 
Statistical analyses
The primary outcome of the study was the yield 
of endoscopy to identify GI neoplasia among 
dermatomyositis patients. We further stratified the 
findings on endoscopy by age and whether signs or 
symptoms were present at the time of endoscopy. 
Statistical analyses comparing differences amongst 
the patients who underwent endoscopy stratified by 
age or presence of symptoms was performed using χ2 
test and Fisher’s exact test was used for categorical 
variables with less than five outcomes. Results were 
displayed as either mean ± SD) or the number of 
outcomes (percentage who underwent endoscopy). 
All analyses were performed using SPSS (IBM version 
23) and a two­tailed P value of < 0.05 was considered 
statistically significant.  
RESULTS
Identification of study cohort
A total of 458 patients were identified by querying 
the electronic medical records for ICD­9 and ICD­10 
codes of dermatomyositis between January 2005 and 
February 2016. We did not identify any additional 
dermatomyositis patients after reviewing the 
rheumatology initiated query of the electronic medical 
record. After chart review of the 458 patients, 295 
of these patients (64%) were excluded because they 
either had dermatomyositis incorrectly coded (n = 
210, 46%) or they were younger than 18 years of 
age (n = 85, 18%). Thus, a total of 163 patients with 
dermatomyositis were included and, of these, 79 
patients had an endoscopy documented within the 
electronic medical record (EGD and/or colonoscopy) as 
shown in Figure 1.
Patient characteristics
Baseline demographic data for the patients who 
4790 July 14, 2017|Volume 23|Issue 26|WJG|www.wjgnet.com
Kidambi TD et al . Yield of endoscopy in dermatomyositis
4791 July 14, 2017|Volume 23|Issue 26|WJG|www.wjgnet.com
other variables, including personal history of cancer. 
The single patient with CRC who did not undergo 
endoscopy was diagnosed with CRC 10 years prior to 
her dermatomyositis diagnosis and no records of the 
initial or subsequent surveillance colonoscopies were 
available in the electronic medical record.
Yield of endoscopy
Of the 47 patients who underwent EGD, no cases of 
malignancy were identified on either the initial exam, or 
if performed, on subsequent exams as shown in Table 2. 
EGD identified two cases of Barrett’s esophagus without 
dysplasia and subsequent EGD at one year identified 
no progression of the Barrett’s in either patients. In 
another patient, gastric intestinal metaplasia without 
dysplasia on random gastric biopsies was identified 
on EGD and the patient underwent a total of seven 
subsequent surveillance EGDs over ten years without 
progression of the gastric intestinal metaplasia. 
There were no cases of malignancy detected in the 
67 patients who underwent colonoscopy as shown in 
Table 2. Of the 12 patients who underwent surveillance 
exams, the majority underwent a single surveillance 
exam in the study period while one patient underwent 
three exams over a ten­year period for surveillance 
purposes because of a previous finding of an advanced 
adenoma (> 10 mm sessile serrated adenoma) and 
a family history of CRC. Seventy­nine percent of the 
colonoscopies were normal and at least one adenoma 
was identified on 14.9% of the initial colonoscopies, 
underwent endoscopy is shown in Table 1. The mean 
age of patients at the time of endoscopy was 56.7 
years with a range from 21 to 88 years and a SD of 
14.4 years; 73% were women. On average, patients 
had dermatomyositis for 6.8 years at the time of 
endoscopy with a SD of 6.6 years; 39 patients (49%) 
had endoscopy within 5 years of their diagnosis. Of 
the two patients with an adenocarcinoma of unknown 
origin, one of these patients was diagnosed based on 
biopsy of a large lymph node found on cross sectional 
imaging while the other patient’s diagnosis was 
made based on biopsy of a liver lesion, with genome 
sequencing of the tumor suggestive of a lung primary. 
The most common indication for EGD and colonoscopy 
was screening in an otherwise asymptomatic patient 
(40.4% and 73.1%, respectively); dysphagia was 
the most common symptom present at time of EGD 
(27.7%) and diarrhea and abdominal pain were the 
most common symptoms prompting colonoscopy 
(16.5%).
Chart review was performed on the patients with 
a diagnosis of dermatomyositis who did not undergo 
endoscopy and the results comparing demographic 
data for these patients compared to those who did 
undergo endoscopy is shown in Supplementary Table 
2. Patients who underwent endoscopic evaluation 
were significantly older at the time of their derma­
tomyositis diagnosis than those who did not (50.1
± 15.9 vs 40.6 ± 15.9, respectively, P < 0.01). No 
significant differences were identified in any of the 
ICD-9 and 10 codes of dermatomyositis 
between 2005-2016 among UCSF 
population
(n  = 458)
Chart review and cross-
reference with rheumatology 
database 
Dermatomyositis 
(n  = 248)
Had endoscopy 
(n  = 79)
No documented 
endoscopy (n  = 84)
Upper endoscopy 
(n  = 47)
Colonoscopy 
(n  = 67)
Excluded: no dermatomyositis 
(n  = 210)
Excluded: individuals < 18 
years of age (n  = 85)
Figure 1  Attached as a powerpoint file.
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with the majority being low risk tubular adenomas 
(9.0%).
Yield of endoscopy stratified by age and symptoms
The yield of endoscopy, stratified by age less than 
or greater than 50 years is shown in Table 3. We 
selected age 50 as the cutoff because many United 
States guidelines commonly recommend average­
risk CRC screening at this age[10]. In addition, multiple 
gastroenterology societies recommend esophageal 
cancer or Barrett’s esophagus screening for high­
risk individuals (i.e., long­standing gastro­esophageal 
reflux disease, Caucasian race, obesity, etc.) at age 
50[11]. There were no statistical differences in the yield 
of EGD for pre-malignant conditions stratified by age. 
The yield of endoscopy, stratified by the presence of 
symptoms is shown in Table 4. There were no identified 
differences in the yield of EGD when symptoms 
were present. Asymptomatic patients undergoing 
colonoscopy were more likely to have a normal 
exam than those with symptoms (86.3% vs 56.3%, 
respectively, P = 0.01), which was attributable to the 
finding of inflammatory bowel disease or microscopic 
colitis in symptomatic patients (25% vs 0% in the 
asymptomatic patients, P < 0.01).
DISCUSSION
Although screening for GI neoplasia is commonly 
recommended in patients with dermatomyositis, the 
yield of endoscopy remains unclear. To that end, we 
report results of the largest study of dermatomyositis 
patients utilizing individual chart­review and the first 
to examine the yield of endoscopy on identification of 
pre­malignant and malignant lesions of the GI tract 
in the United States. In our study of 79 physician­
confirmed dermatomyositis patients, we found the 
yield of endoscopy to be low for the identification of pre-
malignant and malignant GI lesions, even when stratified 
by age, in both asymptomatic and symptomatic patients, 
calling into question an aggressive diagnostic approach 
to identify occult malignancy. No cases of GI malig­
nancy were identified; EGD was of very low yield in the 
identification of significant pathology and colonoscopy 
was only useful in identifying pre­malignant lesions 
(colonic adenomas) in the screening age population 
(patients 50 years and older). 
To date, few studies have evaluated the prevalence 
of GI malignancy in dermatomyositis patients. Previous 
large, population­based studies have found an association 
between dermatomyositis and GI malignancies[3­5]. In 
addition, a single descriptive study[6] of 40 patients with 
dermatomyositis and polymositis at a French hospital 
over a 20 year period suggested that an extensive 
search for malignancy with CT scans of the chest, 
abdomen and pelvis increased the identification of 
malignancy, when compared to routine malignancy 
screening. In contrast, smaller studies[7­9] have found 
a low prevalence of GI neoplasia. These studies found 
gastric cancer in less than 3% of patients[8,9] and CRC 
in less than 2% of patients[7,8] with dermatomyositis. 
In our study, we found no GI malignancies after 
an extensive endoscopic evaluation. One potential 
explanation for these inconsistent findings could be 
the identification of dermatomyositis patients. Studies 
Table 1  Baseline demographic and indications for endoscopy 
n  (%)
Baseline characteristics Had endoscopy (n  = 79)
Age (mean ± SD) 56.7 (14.4)
Male gender 21 (27)
Age at dermatomyositis diagnosis 
(mean ± SD)
50.1 (15.9)
Disease duration (mean ± SD) at 
time of endoscopy
6.8 (6.6)
Personal history of cancer 8 (10.1)
   Melanoma 1
   Prostate 1
   Endometrial 1
   NCC 1
   HCC 1
   RCC 1
   AdenoCA of unknown origin 2
Indication for EGD Had EGD (n = 47)
   Screening 19 (40.4)
   Dysphagia 13 (27.7)
   Dyspepsia/pain   9 (19.1)
   IDA 2 (4.3)
   Weight loss 3 (6.4)
   Abnormal CT scan 1 (2.1)
Indication for colonoscopy Had colonoscopy (n = 67)
   Screening 49 (73.1)
   Surveillance 2 (3.0)
   Diarrhea, abdominal pain 11 (16.4)
   IDA 2 (3.0)
   Weight loss 1 (1.5)
   Blood in stool 1 (1.5)
   Abnormal CT 1 (1.5)
DM: Dermatomyositis; NCC: Nasal cell cancer; HCC: Hepatocellular 
carcinoma; RCC: Renal cell cancer; AdenoCa: Adenocarcinoma; EGD: 
Esophagogastroduodenoscopy; CT: Computed tomography.
Table 2  Yield of endoscopy  n  (%)
Findings on EGD, n = 47
   Malignancy 0 (0)
   Pre-malignancy 3 (6.4)
      Barrett's esophagus without dysplasia 2
      Gastric intestinal metaplasia 1
   Non-malignant findings 8 (17)
      Esophageal varices 2
      H. pylori gastritis 4
      CMV esophagitis 1
      Candida esophagitis 1
   Normal 36 (76.6)
Findings on colonoscopy, n = 67
   Colorectal cancer 0 (0)
   Any adenoma 10 (14.9)
   Inflammatory bowel disease 4 (6.0)
   Normal 53 (79.1)
EGD: Esophagogastroduodenoscopy.
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utilizing ICD code based searches[3,5] and key­word 
search criteria[4] for the diagnosis of dermatomyositis 
and GI malignancy showed higher prevalence for GI 
malignancy compared to smaller studies[7­9], including 
ours, that utilized individual chart review to confirm 
the dermatomyositis diagnosis. In our study, we 
found ICD coding based diagnosis of dermatomyositis 
was inaccurate in 46% of the patients; this calls into 
question the results of these prior studies and suggests 
that rigorous validation is necessary for any future 
population­based dermatomyositis studies. 
Common factors for deciding to pursue endoscopic 
or cross­sectional imaging workup in the general 
population include advancing age and symptoms. 
In our study, there were no significant differences in 
the yield of endoscopy for pre­malignant conditions 
stratified by age and symptoms. In the French cohort 
of 40 dermatomyositis and polymositis patients, six 
patients (15%) were diagnosed with a GI malignancy 
by endoscopy following an abnormal CT scan. 
The results of our study are inconsistent with this 
study, though only two patients in our study had 
an abnormal CT prior to endoscopy. The presence 
of concerning clinical symptoms (i.e., constitutional 
symptoms, anemia, etc.) prompting further evaluation 
with CT scans in all 40 patients, likely accounts 
for the difference in results when compared to our 
study, which largely included asymptomatic patients 
undergoing screening endoscopy. Thus, we conclude 
red­flag symptoms in dermatomyositis patients, as 
in any patient, should prompt investigation for an 
underlying cause, but endoscopy is probably of similar 
yield in dermatomyositis patients as in age­matched 
patients without dermatomyositis. Unfortunately, given 
the retrospective nature of the study we were unable 
to control for all potential confounders including the 
presence of Epstein­Barr virus which in a prior study 
was shown to be associated with gastric cancer risk[12].
Kidambi TD et al . Yield of endoscopy in dermatomyositis
Table 3  Yield of endoscopy stratified by age  n  (%)
Age < 50 (n  = 21) Age ≥ 50 (n  = 26) Age ≥ 50 (n  = 46) P  value
Findings on EGD
   Normal    16 (76.2)   20 (76.9) - 0.95
   Pre-malignancy   1 (4.8)   2 (7.7) - 1.00
   Malignancy 0 (0) 0 (0) - 1.00
   Non-malignant     4 (19.0)      4 (15.4) - 1.00
Findings on Colonoscopy
   Normal    17 (81.0) -    36 (78.3) 0.80
   Any adenoma    1 (4.8) -      9 (20.0) 0.15
   Colorectal cancer 0 (0) - 0 (0) 1.00
   Inflammatory bowel disease   2 (9.5) -    2 (4.3) 0.58
EGD: Esophagogastroduodenoscopy.
Table 4  Yield of endoscopy by presence of symptoms  n  (%)
Asymptomatic Symptomatic P  value
n  = 19 n  = 51  n  = 28 n  = 16
Findings on EGD
   Normal   15 (78.9) -    21 (75.0) -    0.75
   Pre-malignancy 0 (0) -     3 (10.7) -    0.26
      Barrett's without dysplasia - -   2 (7.1) - -
      Gastric intestinal metaplasia without dysplasia - -   1 (3.6) - -
   Malignancy 0 (0) - 0 (0) - -
   Non-malignant     4 (21.1) -      4 (14.3) -    0.70
      Varices     2 (10.5) - - - -
      Helicobacter pylori gastritis     2 (10.5) -    2 (7.1) - -
      Cytomegalovirus esophagitis - -    1 (3.6) - -
      Candida esophagitis - -    1 (3.6) - -
Findings on Colonoscopy  
   Normal -    44 (86.3) -     9 (56.3)    0.01
   Pre-malignancy -      7 (13.7) -     3 (18.8)    0.69
      Advanced adenoma -    1 (2.0) -   1 (6.3) -
      Low risk tubular adenoma -    5 (9.8) -   1 (6.3) -
      ≥ 3 tubular adenomas -    1 (2.0) -   1 (6.3) -
   Malignancy - 0 (0) - 0 (0) -
   Non-malignant findings - 0 (0) -   4 (25) < 0.01
      IBD - - -     3 (18.8) -
      Microscopic colitis - - -   1 (6.3) -
EGD: Esophagogastroduodenoscopy; IBD: Inflammatory bowel disease.
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Our study had many strengths. Because the 
data were generated from routine clinical care, the 
findings are likely to be accurate and generalizable 
to other clinical centers caring for patients with 
dermatomyositis. A particular strength of our data is 
that individual chart review was conducted to verify the 
diagnosis of dermatomyositis as well as the findings on 
endoscopy and pathologic diagnoses. To our knowledge 
this is the largest sample size of dermatomyositis 
patients in a study utilizing chart review and therefore 
is a valuable addition to the literature. As this is the 
only study examining the yield of endoscopy in both 
symptomatic and asymptomatic dermatomyositis 
patients, the results are likely to help inform decisions 
in the routine clinical care of patients.
There were several limitations to our study. Because 
the study was conducted in a single tertiary care 
center, there was loss to follow­up and it is possible 
that, despite reviewing the electronic medical record 
including uploaded records from care received outside 
of UCSF, endoscopies performed elsewhere were not 
captured and as a result cases of cancer were missed. 
Furthermore, the age of patients in our study was 
relatively young which may have reduced the likelihood 
of identifying malignancy, as older age has been 
shown to be a risk factor for neoplasia in this patient 
population[13]. However, this supports our finding that 
the risk of neoplasia is likely similar to the general, 
age­matched population and screening outside of the 
guideline recommendations may not be needed where 
an adenoma detection rate of 20%­30% is expected 
in the United States. Additionally, a large number 
of patients with dermatomyositis did not undergo 
endoscopy so cases of cancer could have been missed. 
However, this was mitigated by the fact that the entire 
medical record was reviewed, since a cancer diagnosis 
likely would have been mentioned in clinic notes or 
within the problem lists. Furthermore, because there 
is wide variation in practice it is possible that patients 
who underwent endoscopy may have been perceived 
by their physicians to be at higher risk for malignancy 
but this would have biased our study towards an 
overestimate of the prevalence of malignancy, which 
is less of a concern given the negative findings of our 
study. While this was the largest study of its kind, 
the power to identify differences in endoscopy yield 
stratified by age was low. For example, to detect a 
5% difference in the prevalence of colonic adenomas 
assuming a prevalence 25% would require over 
1000 patients 50 years and older and another 1000 
patients younger than 50. Given dermatomyositis 
is a rare disease, an adequately powered study was 
not feasible. Nevertheless, the absolute values and 
findings in our study are still meaningful, interpretable 
and may be more applicable to the clinician caring for 
dermatomyositis than the previous larger population 
based studies that did not utilize individual level chart 
review.
In conclusion, this study suggests that the yield of 
endoscopy in dermatomyositis for the identification 
of pre­malignant and malignant GI lesions is low in 
the United States. In fact, our study identified no 
cases of upper GI or colon cancers. Moreover, even 
when stratified by age or the presence of symptoms, 
endoscopy was of low yield, raising the question 
of whether routine use of aggressive screening for 
GI malignancy is necessary and justified. Further 
studies utilizing rigorously validated search strategies 
are necessary to determine the absolute risk of GI 
malignancy in patients with dermatomyositis to inform 
whether aggressive surveillance is needed beyond 




Dermatomyositis is associated with an increased risk of gastrointestinal (GI) 
malignancies based on large-population based studies. These prior studies 
utilized code-based search strategies and did not perform individual chart 
review. 
Research frontiers
Endoscopy is now used to screen for GI neoplasias, but the yield of endoscopy 
in this patient population with dermatomyositis is not known. Understanding the 
yield of endoscopy could help inform clinical care of these patients.
Innovations and breakthroughs
By utilizing individual chart review, we provided an accurate estimate of 
prevalence of GI neoplasia in this population. They found that endoscopy 
identified no cases of malignancy and was of low yield, likely similar to the 
general population, in the identification of pre-malignant findings. Code-based 
searched strategies were inaccurate in the identification of dermatomyositis, 
calling into question the results of prior population-based studies. 
Applications
The association between increased GI malignancy and dermatomyositis may 
be lower than previously reported.
Peer-review
This is an observational study attempting to quantify the actual risk of GI 
malignancy in patients with dermatomyositis and the yield of routine screening 
endoscopy in this population. The study is performed by retrospective chart 
review after identifying patients with dermatomyositis and reviewing endoscopy 
results. The paper is well written with good numbers and a thorough search 
method and provides evidence for management of a rare condition. 
REFERENCES
1 Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. 
Lancet 2003; 362: 971-982 [PMID: 14511932 DOI: 10.1016/
S0140-6736(03)14368-1]
2 Dalakas MC. Polymyositis, dermatomyositis and inclusion-body 
myositis. N Engl J Med 1991; 325: 1487-1498 [PMID: 1658649 
DOI: 10.1056/NEJM199111213252107]
3 Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, 
Airio A, Evans SR, Felson DT. Frequency of specific cancer 
types in dermatomyositis and polymyositis: a population-based 
study. Lancet 2001;357: 96-100 [PMID: 11197446 DOI: 10.1016/
S0140-6736(00)03540-6]
4 Buchbinder R, Forbes A, Hall S, Dennett X, Giles G. Incidence 
of malignant disease in biopsy-proven inflammatory myopathy. 
Kidambi TD et al . Yield of endoscopy in dermatomyositis
 COMMENTS
4795 July 14, 2017|Volume 23|Issue 26|WJG|www.wjgnet.com
A population-based cohort study. Ann Intern Med 2001; 134: 
1087-1095 [PMID: 11412048]
5 Chen YJ, Wu CY, Huang YL, Wang CB, Shen JL, Chang YT. 
Cancer risks of dermatomyositis and polymyositis: a nationwide 
cohort study in Taiwan. Arthritis Res Ther 2010; 12: R70 [PMID: 
20398365 DOI: 10.1186/ar2987]
6 Sparsa A, Liozon E, Herrmann F, Ly K, Lebrun V, Soria P, 
Loustaud-Ratti V, Bouyssou-Gauthier ML, Boulinguez S, Bédane 
C, Jauberteau MO, Vidal E, Bonnetblanc JM. Routine vs extensive 
malignancy search for adult dermatomyositis and polymyositis: a 
study of 40 patients. Arch Dermatol 2002; 138: 885-890 [PMID: 
12071815]
7 András C, Ponyi A, Constantin T, Csiki Z, Szekanecz E, Szodoray 
P, Dankó K. Dermatomyositis and polymyositis associated with 
malignancy: a 21-year retrospective study. J Rheumatol 2008; 35: 
438-444 [PMID: 18203322]
8 Fang YF, Wu YJ, Kuo CF, Luo SF, Yu KH. Malignancy in 
dermatomyositis and polymyositis: analysis of 192 patients. Clin 
Rheumatol 2016; 35: 1977-1984 [PMID: 27210465 DOI: 10.1007/
s10067-016-3296-8]
9 Limaye V, Luke C, Tucker G, Hill C, Lester S, Blumbergs P, 
Roberts-Thomson P. The incidence and associations of malignancy 
in a large cohort of patients with biopsy-determined idiopathic 
inflammatory myositis. Rheumatol Int 2013; 33: 965-971 [PMID: 
22833242 DOI: 10.1007/s00296-012-2489-y]
10 US Preventive Services Task Force., Bibbins-Domingo K, 
Grossman DC, Curry SJ, Davidson KW, Epling JW Jr, García 
FAR, Gillman MW, Harper DM, Kemper AR, Krist AH, Kurth AE, 
Landefeld CS, Mangione CM, Owens DK, Phillips WR, Phipps 
MG, Pignone MP, Siu AL. Screening for Colorectal Cancer: US 
Preventive Services Task Force Recommendation Statement. 
JAMA 2016; 315: 2564-2575 [PMID: 27304597]
11 Spechler SJ, Souza RF. Barrett’s esophagus. N Engl J Med 2014; 
371: 836-845 [PMID: 25162890 DOI: 10.1056/NEJMra1314704]
12 Yamashita K, Hosokawa M, Hirohashi S, Arimura Y, Endo T, 
Denno R, Ikeda T, Imai K. Epstein-Barr virus-associated gastric 
cancer in a patient with dermatomyositis. Intern Med 2001; 40: 
96-99 [PMID: 11300169]
13 Marie I, Hatron PY, Levesque H, Hachulla E, Hellot MF, 
Michon-Pasturel U, Courtois H, Devulder B. Influence of age on 
characteristics of polymyositis and dermatomyositis in adults. 
Medicine (Baltimore) 1999; 78: 139-147 [PMID: 10352646]
P- Reviewer: Chow CFK, Treeprasertsuk S    S- Editor: Qi Y 
L- Editor: A    E- Editor: Zhang FF
Kidambi TD et al . Yield of endoscopy in dermatomyositis
                                      © 2017 Baishideng Publishing Group Inc. All rights reserved.
Published by Baishideng Publishing Group Inc






I S S N  1 0  0 7  -   9  3 2  7
9    7 7 1 0  07   9 3 2 0 45
2  6
